EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160 | +300.0% | 46,970 | +757.6% | 0.01% | +250.0% |
| Q2 2023 | $40 | -52.9% | 5,477 | -33.3% | 0.00% | -50.0% |
| Q1 2023 | $85 | -12.4% | 8,214 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $97 | -100.0% | 8,243 | -16.9% | 0.00% | -50.0% |
| Q3 2022 | $208,000 | -46.4% | 9,916 | -20.8% | 0.01% | -27.3% |
| Q2 2022 | $388,000 | -24.4% | 12,516 | +0.2% | 0.01% | -8.3% |
| Q1 2022 | $513,000 | -17.7% | 12,495 | -12.9% | 0.01% | -7.7% |
| Q4 2021 | $623,000 | -12.9% | 14,343 | +0.5% | 0.01% | -18.8% |
| Q3 2021 | $715,000 | -23.8% | 14,276 | -4.1% | 0.02% | -11.1% |
| Q2 2021 | $938,000 | -13.6% | 14,886 | +27.4% | 0.02% | -18.2% |
| Q1 2021 | $1,086,000 | +3.1% | 11,685 | -0.6% | 0.02% | 0.0% |
| Q4 2020 | $1,053,000 | -13.3% | 11,755 | 0.0% | 0.02% | -21.4% |
| Q3 2020 | $1,215,000 | +30.6% | 11,755 | 0.0% | 0.03% | +21.7% |
| Q2 2020 | $930,000 | +35.0% | 11,755 | -1.3% | 0.02% | +21.1% |
| Q1 2020 | $689,000 | +5.7% | 11,906 | -1.5% | 0.02% | +35.7% |
| Q4 2019 | $652,000 | +0.8% | 12,087 | -2.3% | 0.01% | -6.7% |
| Q3 2019 | $647,000 | +7.3% | 12,372 | -0.9% | 0.02% | +15.4% |
| Q2 2019 | $603,000 | -6.5% | 12,479 | -2.2% | 0.01% | -7.1% |
| Q1 2019 | $645,000 | -14.8% | 12,765 | 0.0% | 0.01% | -26.3% |
| Q4 2018 | $757,000 | -17.1% | 12,765 | -7.9% | 0.02% | +5.6% |
| Q3 2018 | $913,000 | +30.4% | 13,865 | 0.0% | 0.02% | +28.6% |
| Q2 2018 | $700,000 | -9.0% | 13,865 | -5.1% | 0.01% | -6.7% |
| Q1 2018 | $769,000 | +13.3% | 14,608 | 0.0% | 0.02% | +15.4% |
| Q4 2017 | $679,000 | -8.0% | 14,608 | -19.9% | 0.01% | -18.8% |
| Q3 2017 | $738,000 | +16.0% | 18,247 | -2.7% | 0.02% | +14.3% |
| Q2 2017 | $636,000 | +16.9% | 18,747 | 0.0% | 0.01% | +16.7% |
| Q1 2017 | $544,000 | -17.5% | 18,747 | -6.5% | 0.01% | -20.0% |
| Q4 2016 | $659,000 | +3.3% | 20,058 | -0.9% | 0.02% | +15.4% |
| Q3 2016 | $638,000 | – | 20,233 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |